Eversept Partners’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q1 | – | Hold |
0
| – | – | – | 98 |
|
|
2021
Q4 | – | Hold |
0
| – | – | – | 114 |
|
|
2021
Q3 | – | Sell |
-54,500
| Closed | -$11M | – | 112 |
|
|
2021
Q2 | $11M | Buy |
+54,500
| New | +$11M | 0.73% | 27 |
|
|
2021
Q1 | – | Hold |
0
| – | – | – | 90 |
|
|
2020
Q1 | – | Sell |
-73,009
| Closed | -$16M | – | 75 |
|
|
2019
Q4 | $16M | Buy |
73,009
+22,100
| +43% | +$4.84M | 2.82% | 11 |
|
|
2019
Q3 | $8.63M | Sell |
50,909
-6,940
| -12% | -$1.18M | 2.68% | 10 |
|
|
2019
Q2 | $10.6M | Buy |
57,849
+19,620
| +51% | +$3.6M | 2.97% | 11 |
|
|
2019
Q1 | $7.03M | Buy |
38,229
+1,737
| +5% | +$320K | 2.05% | 14 |
|
|
2018
Q4 | $6.05M | Sell |
36,492
-11,600
| -24% | -$1.92M | 3.27% | 8 |
|
|
2018
Q3 | $9.27M | Buy |
48,092
+13,270
| +38% | +$2.56M | 4.07% | 8 |
|
|
2018
Q2 | $5.92M | Sell |
34,822
-10,000
| -22% | -$1.7M | 2.71% | 13 |
|
|
2018
Q1 | $7.31M | Sell |
44,822
-13,300
| -23% | -$2.17M | 3.39% | 12 |
|
|
2017
Q4 | $8.71M | Buy |
+58,122
| New | +$8.71M | 5.01% | 4 |
|